JPH0259125B2 - - Google Patents

Info

Publication number
JPH0259125B2
JPH0259125B2 JP55151504A JP15150480A JPH0259125B2 JP H0259125 B2 JPH0259125 B2 JP H0259125B2 JP 55151504 A JP55151504 A JP 55151504A JP 15150480 A JP15150480 A JP 15150480A JP H0259125 B2 JPH0259125 B2 JP H0259125B2
Authority
JP
Japan
Prior art keywords
acridine
bis
piperidino
methyl
ethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP55151504A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5673065A (en
Inventor
Chadoitsuku Murudotsuku Keisu
Robaato Damiani Maatein
Eemiru Doru Furederitsuku
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of JPS5673065A publication Critical patent/JPS5673065A/ja
Publication of JPH0259125B2 publication Critical patent/JPH0259125B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/06—Oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
JP15150480A 1979-10-31 1980-10-30 Substituted 3*66bis*aminoalkoxy*acridines and their manufacture Granted JPS5673065A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8980579A 1979-10-31 1979-10-31

Publications (2)

Publication Number Publication Date
JPS5673065A JPS5673065A (en) 1981-06-17
JPH0259125B2 true JPH0259125B2 (en, 2012) 1990-12-11

Family

ID=22219661

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15150480A Granted JPS5673065A (en) 1979-10-31 1980-10-30 Substituted 3*66bis*aminoalkoxy*acridines and their manufacture

Country Status (12)

Country Link
EP (1) EP0031407B1 (en, 2012)
JP (1) JPS5673065A (en, 2012)
KR (1) KR840002088B1 (en, 2012)
AT (1) ATE26708T1 (en, 2012)
AU (1) AU538477B2 (en, 2012)
CA (1) CA1170260A (en, 2012)
DE (1) DE3071953D1 (en, 2012)
DK (2) DK460080A (en, 2012)
ES (1) ES496412A0 (en, 2012)
HK (1) HK4491A (en, 2012)
IE (1) IE52711B1 (en, 2012)
ZA (1) ZA806195B (en, 2012)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0263325U (en, 2012) * 1988-10-31 1990-05-11
JPH0740447U (ja) * 1991-12-04 1995-07-18 天龍化学工業株式会社 箱形容器における注出口装置

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0180812B1 (en) * 1984-11-09 1991-05-15 American Cyanamid Company 3,6 bis(substituted) acridine derivatives
WO2011156889A1 (en) * 2010-06-14 2011-12-22 Trt Pharma Inc. Novel modulators of nrf2 and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1727480A (en) * 1926-07-08 1929-09-10 Winthrop Chem Co Inc New dialkylamino-alkyl derivatives of the 3.6-dihydroxyacridine
DE490418C (de) * 1926-07-09 1930-02-05 I G Farbenindustrie Akt Ges Verfahren zur Darstellung von basischen AEthern der Acridinreihe
US3740403A (en) * 1971-11-05 1973-06-19 American Cyanamid Co 3,6-bis-(dialkylaminoalkoxy)acridines
EP0012139A1 (en) * 1978-12-14 1980-06-25 American Cyanamid Company Therapeutic agent for stimulating the immune response in a mammal

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0263325U (en, 2012) * 1988-10-31 1990-05-11
JPH0740447U (ja) * 1991-12-04 1995-07-18 天龍化学工業株式会社 箱形容器における注出口装置

Also Published As

Publication number Publication date
IE52711B1 (en) 1988-02-03
KR840002088B1 (ko) 1984-11-14
IE802066L (en) 1981-04-30
ES8106893A1 (es) 1981-10-01
AU6314180A (en) 1981-05-07
DK460180A (da) 1981-05-01
CA1170260A (en) 1984-07-03
ES496412A0 (es) 1981-10-01
AU538477B2 (en) 1984-08-16
JPS5673065A (en) 1981-06-17
ATE26708T1 (de) 1987-05-15
DK460080A (da) 1981-05-01
DE3071953D1 (en) 1987-05-27
HK4491A (en) 1991-01-18
EP0031407B1 (en) 1987-04-22
KR830004256A (ko) 1983-07-09
ZA806195B (en) 1982-05-26
EP0031407A1 (en) 1981-07-08

Similar Documents

Publication Publication Date Title
IE861395L (en) Alfuzosine compositions
EP0659412A2 (en) Inhibition of the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder
JPH08231540A (ja) エストロゲン作動薬
RU2166316C2 (ru) Способ для лечения и предупреждения разрежения кости и остеопороза и соединения для него
HU220607B1 (hu) Benzotiofénszármazékok alkalmazása angiogenezis és érképző betegségek gátlására alkalmas gyógyszerkészítmények előállítására
JPH07196501A (ja) 胸部疾患を抑制するための医薬組成物
EP0682947B1 (en) Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia
US4766117A (en) Antiinflammatory compositions and methods
US20080161307A1 (en) Organic Compounds
JPH0259125B2 (en, 2012)
JPH07196492A (ja) 体重増加を抑制する、または体重減少を誘発するための医薬組成物
JPS63162621A (ja) 頻尿治療剤
JP2906512B2 (ja) 抗潰瘍剤
JPH025735B2 (en, 2012)
JP2872695B2 (ja) 腎炎の治療剤
JPS615017A (ja) 抗潰瘍組成物
CA2163158A1 (en) Methods for inhibiting bone loss
EP0623346B1 (en) Inhibitor for metastasis of malignant tumor
JPS591474A (ja) ピペラジン環を有するゲラニルゲラニル酢酸アミド化合物またはその塩類
US3622676A (en) Smoking suppression
US4874757A (en) Antinflammatory compositions and methods
JPH02138123A (ja) 心不全治療用医薬組成物
KR20010024768A (ko) 혈관성 두통에 대한 국소 마취제의 신규 용도
JPH09506902A (ja) 前立線癌の化学療法剤の補助剤
EP0900796B1 (en) Preventives and remedies for ischemic intestinal lesion and ileus